If you have used the birth control Essure any time since its introduction in 2002, be sure to read the following information. A mass tort is now being brought against Bayer Healthcare based on allegations of Essure causing serious side effects and complications in women.
In fact, Essure has been linked to nearly 30,000 adverse events between 2002 and 2017. Though this device is now being discontinued, the lawsuits against it will continue for years. If you have endured harm or health dangers due to Essure, this is your time to demand compensation.
What Is Essure, and Why Is It Dangerous?
Essure was developed as a birth control device for women who were certain they did not want any more children. Many women choice Essure because the simple process only took 10 minutes without anesthesia and claimed to prevent all future pregnancies.
However, thousands of women experienced serious health complications after their Essure implants. The Essure implants contain nickel-titanium alloys, materials known to cause allergic reactions including rashes, itching, and hives. Other complications include:
- Abdominal pain
- Irregular menstruation
- Weight fluctuations
- Unprevented pregnancy
- Vaginal infections
Contact a Mass Tort Lawyer Now
If you have experienced any of the symptoms associated with Essure, you could qualify to participate in the mass tort lawsuit against Essure. You should speak with an attorney who specializes in mass tort to determine if you could be entitled to compensation.
Since Essure was marketed as a safe, highly effective form of birth control, the team at Catania and Catania can use your experiences of adverse health effects to pursue compensation on your behalf. Call 1-800-253-5523 to schedule your free case evaluation with Catania and Catania in Tampa, Florida today to learn more.
Latest posts by Catania Catania Law Team (see all)
- First Steps to Take After a Bus Accident - April 19, 2019
- What to Do When You Suspect Nursing Home Negligence - April 12, 2019
- A SWOT Analysis of Florida’s Workers’ Compensation - April 5, 2019